Implications of smoking in the context of COVID-19

Authors

Keywords:

tobacco, cigarette, smoking, nicotine, SARS-CoV-2, COVID-19.

Abstract

Introduction: With the spread of the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2), questions about the risk factors that influence the coronavirus disease 2019 (COVID-19) have emerged. A widely debated issue has been the potential effect of smoking on SARS-CoV-2 infection rates and the clinical consequences of COVID-19.
Objective: To elucidate the implications of smoking in the context of COVID-19.
Development: In the literature consulted, several pathophysiological mechanisms that support the deleterious effect of smoking in the context of COVID-19 were identified: upregulation of angiotensin-converting enzyme 2; increased expression/activity of transmembrane serine protease 2, cathepsin B/L and furin; immunoinflammation and immunosuppression; upregulation of phosphodiesterase 4; encephalic hemovascular alterations; and morphofunctional modifications of the lung parenchyma.
Conclusions: Smoking has a deleterious effect on patients bearing COVID-19. In this harmful association, there are pathophysiological mechanisms that may make smokers -active or passive ones- more vulnerable to SARS-CoV-2 infection or more likely to present with an unfavorable evolution once they have developed COVID-19.

Downloads

References

1. Chatkin JM, Godoy I. Are smoking, environmental pollution, and weather conditions risk factors for COVID-19? J Bras Pneumo. 2020 [acceso: 15/04/2021]; 46(5): e20200183. Disponible en: https://dx.doi.org/10.36416/1806-3756/e20200183

2. Piñera-Castro HJ. COVID-19 and Guillain-Barré Syndrome: A fortuitous relationship? Rev Mex Neuroci. 2020 [acceso: 15/04/2021]; 21(5): 205-14. Disponible en: https://doi.org/10.24875/RMN.20000079

3. Grundy EJ, Suddek T, Filippidis FT, Majeed A, Coronini-Cronberg S. Smoking, SARS-CoV-2 and COVID-19: A review of reviews considering implications for public health policy and practice. Tob Induc Dis. 2020 [acceso: 15/04/2021]; 18(julio): 58. Disponible en: https://doi.org/10.18332/tid/124788

4. Vardavas CI, Nikitara K. COVID-19 and smoking: A systematic review of the evidence. Tob Induc Dis. 2020 [acceso: 15/04/2021]; 18:20. Disponible en: https://doi.org/10.18332/tid/119324

5. Kaur G, Lungarella G, Rahman I. SARS-CoV-2 COVID-19 susceptibility and lung inflammatory storm by smoking and vaping. Journal of Inflammation. 2020 [acceso: 15/04/2021]; 17:21. Disponible en: https://journal-inflammation.biomedcentral.com/track/pdf/10.1186/s12950-020-00250-8.pdf

6. Reddy RK, Charles WN, Sklavounos A, Dutt A, Seed PT, Khajuria A. The effect of smoking on COVID‐19 severity: A systematic review and meta‐analysis. J Med Virol. 2021 [acceso: 15/04/2021]; 93(2): 1045-1056. Disponible en: https://doi.org/10.1002/jmv.26389

7. WHO. WHO statement: Tobacco use and COVID-19. 11 Mayo 2020. [acceso: 15/04/2021]. Disponible en: https://www.who.int/news-room/detail/11-05-2020-who-statementtobacco-use-and-covid-19

8. Aymerich M, Sánchez E. Del conocimiento científico de la investigación clínica a la cabecera del enfermo: las guías de práctica clínica e implementación. Gac Sanit . 2004 [acceso: 15/04/2021]; 18(4): 326-334. Disponible en: https://scielosp.org/article/gs/2004.v18n4/326-334/#

9. Pranata R, Soeroto AY, Huang I, Lim MA, Santoso P, Permana H, Lukito AA. Effect of chronic obstructive pulmonary disease and smoking on the outcome of COVID-19. Int J Tuberc Lung Dis. 2020 [acceso: 16/04/2021]; 24(8): 838-843. Disponible en: https://doi.org/10.5588/ijtld.20.0278

10. Chakladar J, Shende N, Li WT, Rajasekaran M, Chang EY, Ongkeko WM. Smoking-Mediated Upregulation of the Androgen Pathway Leads to Increased SARS-CoV-2 Susceptibility. Int J Mol Sci. 2020 [acceso: 16/04/2021]; 21(10): 3627. Disponible en: https://doi.org/10.3390/ijms21103627

11. Hopkinson NS, Rossi N, El-Sayed_Moustafa J, Laverty AA, Quint JK, Freidin M, et al. Current smoking and COVID-19 risk: results from a population symptom app in over 2.4 million people. Thorax. 2021 [acceso: 16/04/2021]; 76(7): 714-22. Disponible en: https://doi.org/10.1136/thoraxjnl-2020-215119

12. Li J, Long X, Zhang Q, Fang X, Li N, Fedorova B, Hu S, Li Jh, Xiong N, Lin Z. Tobacco smoking confers risk for severe COVID-19 unexplainable by pulmonary imaging. J Intern Med. 2021 [acceso: 16/04/2021]; 289(4): 574-83. Disponible en: https://doi.org/10.1111/joim.13190

13. Farsalinos K, Barbouni A, Poulas K, Polosa R, Caponnetto P, Niaura R. Current smoking, former smoking, and adverse outcome among hospitalized COVID-19 patients: a systematic review and meta-analysis. Ther Adv Chronic Dis. 2020 [acceso: 16/04/2021]; 11: 1-14. Disponible en: https://doi.org/10.1177/2040622320935765

14. Alqahtani JS, Oyelade T, Aldhahir AM, Alghamdi SM, Almehmadi M, Alqahtani AS, et al. Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis. PLoS ONE. 2020 [acceso: 16/04/2021]; 15(5): e0233147. Disponible en: https://doi.org/10.1371/journal.pone.0233147

15. Umnuaypornlert A, Kanchanasurakit S, Lucero-Prisno DE, Saokaew S. Smoking and risk of negative outcomes among COVID-19 patients: A systematic review and meta-analysis. Tob Induc Dis. 2021 [acceso: 16/04/2021]; 19: 09. Disponible en: https://doi.org/10.18332/tid/132411

16. Jiménez-Ruiz CA, López-Padilla D, Alonso-Arroyo A, Aleixandre-Benavent R, Solano-Reina S, Granda-Orivee JI. COVID-19 y tabaquismo: revisión sistemática y metaanálisis de la evidencia. Arch Bronconeumol. 2020 [acceso: 17/04/2021]; 57(S1): 21-34. Disponible en: https://doi.org/10.1016/j.arbres.2020.06.024

17. Smith JC, Sausville EL, Girish V, Yuan ML, Vasudevan A, John KM, et al. Cigarette Smoke Exposure and Inflammatory Signaling Increase the Expression of the SARS-CoV-2 Receptor ACE2 in the Respiratory Tract. Developmental Cell. 2020 [acceso: 17/04/2021]; 53(5): 514-29. Disponible en: https://doi.org/10.1016/j.devcel.2020.05.012

18. Engin AB, Engin ED, Engin A. Two important controversial risk factors in SARS-CoV-2 infection: Obesity and smoking. Environmental Toxicology and Pharmacology. 2020 [acceso: 17/04/2021]; 78: 103411. Disponible en: https://doi.org/10.1016/j.etap.2020.103411

19. Oliveira-da Silva AL, Costa Moreira K, Regina Martins S. COVID-19 and smoking: a high-risk association. Cad Saúde Pública. 2020 [acceso: 17/04/2021]; 36(5): e00072020. Disponible en: https://doi.org/10.1590/0102-311x00072020

20. Sharif-Askari NS, Sharif-Askari FS, Alabed M, Temsah M, Heialy SA, Hamid Q, Halwani R. Airways Expression of SARS-CoV-2 Receptor, ACE2, and TMPRSS2 Is Lower in Children Than Adults and Increases with Smoking and COPD. Molecular Therapy: Methods & Clinical Development. 2020 [acceso: 18/04/2021]; 18: 1-6. Disponible en: https://doi.org/10.1016/j.omtm.2020.05.013

21. Lee AC, Chakladar J, Li WT, Chen C, Chang EY, Wang-Rodriguez J, Ongkeko WM. Tobacco, but Not Nicotine and Flavor-Less Electronic Cigarettes, Induces ACE2 and Immune Dysregulation. Int J Mol Sci. 2020 [acceso: 18/04/2021]; 21(15): 5513. Disponible en: https://doi.org/10.3390/ijms21155513

22. Olds JL, Kabbani N. Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population? The FEBS Journal. 2020 [acceso: 18/04/2021]; 287(17): 3651-5. Disponible en: https://doi.org/10.1111/febs.15303

23. Archie SR, Cucullo L. Cerebrovascular and Neurological Dysfunction under the Threat of COVID-19: Is There a Comorbid Role for Smoking and Vaping? Int J Mol Sci. 2020 [acceso: 19/04/2021]; 21: 3916. Disponible en: https://doi.org/10.3390/ijms21113916

24. Lugnier C, Al-Kuraishy HM, Rousseau E. PDE4 inhibition as a therapeutic strategy for improvement of pulmonary dysfunctions in Covid-19 and cigarette smoking. Biochemical Pharmacology. 2021 [acceso: 19/04/2021]; 185: 114431. Disponible en: https://doi.org/10.1016/j.bcp.2021.114431

25. Zhao Q, Meng M, Kumar R, Wu Y, Huang J, Lian N, et al. The impact of COPD and smoking history on the severity of COVID‐19: A systemic review and meta‐analysis. J Med Virol. 2020 [acceso: 18/04/2021]; 92(10): 1915-21. Disponible en: https://doi.org/10.1002/jmv.25889

26. Cattaruzza MS, Zagà V, Gallus S, D'Argenio P, Gorini G. Tobacco smoking and COVID-19 pandemic: old and new issues. A summary of the evidence from the scientific literature. Acta Biomed. 2020 [acceso: 19/04/2021]; 91(2): 106-112. Disponible en: https://doi.org/10.23750/abm.v91i2.9698

Downloads

Published

2021-12-30

How to Cite

1.
Piñera-Castro HJ, Ruiz González LA. Implications of smoking in the context of COVID-19. Rev Cubana Med Milit [Internet]. 2021 Dec. 30 [cited 2025 Apr. 5];51(1):e02201457. Available from: https://revmedmilitar.sld.cu/index.php/mil/article/view/1457

Issue

Vol. 51 No. 1 (2022): January - March

Section

Review Article

License

Authors who have publications with this Journal accept the following terms:

  • The authors will retain their copyright and guarantee the Journal the right of first publication of their work, which will simultaneously be subject to the Creative Commons Attribution License. The content presented here can be shared, copied and redistributed in any medium or format; Can be adapted, remixed, transformed or created from the material, using the following terms: Attribution (giving appropriate credit to the work, providing a link to the license, and indicating if changes have been made); non-commercial (you cannot use the material for commercial purposes) and share-alike (if you remix, transform or create new material from this work, you can distribute your contribution as long as you use the same license as the original work).
  • The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (for example: depositing it in an institutional electronic archive or publishing it in a monographic volume) as long as the initial publication in this Journal is indicated.
  • Authors are allowed and recommended to disseminate their work through the Internet (e.g., in institutional electronic archives or on their website) before and during the submission process, which can produce interesting exchanges and increase citations. of the published work.